MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Indivior PLC Company Profile (LON:INDV)

Consensus Ratings for Indivior PLC (LON:INDV) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: GBX 254.17

Analysts' Ratings History for Indivior PLC (LON:INDV)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2016Jefferies GroupBoost Price TargetBuyGBX 245 -> GBX 285View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2016Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/14/2016Morgan StanleyUpgradeOverweightGBX 190 -> GBX 280View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Deutsche BankBoost Price TargetBuyGBX 200 -> GBX 280View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Citigroup Inc.Reiterated RatingBuyGBX 230View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016RBC CapitalReiterated RatingUnderperformGBX 140View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015Oriel Securities LtdReiterated RatingBuyGBX 280View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Indivior PLC (LON:INDV)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Indivior PLC (LON:INDV)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Indivior PLC (LON:INDV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Indivior PLC (LON:INDV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/12/2016Tassé,DanielInsiderBuy3,903GBX 161£6,283.83Tweet This Trade  Share This Trade on StockTwits
5/13/2015Daniel TasséInsiderBuy6,209GBX 229.28£14,236Tweet This Trade  Share This Trade on StockTwits
3/27/2015Shaun ThaxterInsiderBuy20,000GBX 196£39,200Tweet This Trade  Share This Trade on StockTwits
3/26/2015Shaun ThaxterInsiderBuy10,000GBX 197.17£19,717Tweet This Trade  Share This Trade on StockTwits
2/16/2015Shaun ThaxterInsiderBuy35,000GBX 161.59£56,556.50Tweet This Trade  Share This Trade on StockTwits
2/13/2015Cary ClaiborneInsiderBuy62,000GBX 166.24£103,068.80Tweet This Trade  Share This Trade on StockTwits
2/12/2015Cary ClaiborneInsiderBuy23,780GBX 170£40,426Tweet This Trade  Share This Trade on StockTwits
2/11/2015Shaun ThaxterInsiderBuy10,000GBX 163.36£16,336Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Indivior PLC (LON:INDV)
DateHeadline
06/28/16 02:27 AMWill Indivior plc (+71%), Serco Group plc (+33%) & Indus Gas Limited (+105%) be among 2016’s big winners? -
06/24/16 04:39 PMIndivior Plc (LON:INDV) price target maintained to GBX0 as announced today by Stifel
06/23/16 04:59 PMIndivior (LON:INDV) Broker Roundup - Fiscal Standard
06/17/16 07:21 AMMorgan Stanley Upgraded Indivior Plc (LON:INDV) To 'Overweight' - FTSE News
06/15/16 04:41 PMStopping opioid addiction may be impossible unless... - NJ.com (blog)
06/10/16 07:23 AMAre GlaxoSmithKline plc, Indivior plc and Alliance Pharma plc buys ahead of a potential Brexit? - Motley Fool UK
06/09/16 04:48 PMJefferies & Co maintained Indivior PLC (LON:INDV) as 'Buy' With 245 PT - FTSE News
06/07/16 04:39 PMETF’s with exposure to Indivior Plc : June 7, 2016 -
06/07/16 07:09 AMIndivior Plc (LON:INDV) Receives 'Hold' Rating From Brokers At Cantor Fitzgerald - FTSE News
06/07/16 07:09 AMDeutsche Bank reiterated Indivior Plc (LON:INDV) as 'Buy' With 280 PT - FTSE News
06/06/16 08:13 AMEquities Research Analysts' Price Target Changes for June, 6th (ADS, AMBA, AVGO, BAYN, BBVA, BMW, BNP, CIEN ... - Let Me Know About This
06/06/16 08:13 AMEuropean Stocks Advance After Weekly Decline as Miners Climb - Bloomberg
06/03/16 04:59 PMIndivior PLC (LON:INDV) Given Average Recommendation of “Buy” from Analysts - Let Me Know About This
06/02/16 04:53 PMIndivior (LON:INDV) Morning Trade Volumes - Share Trading News - Share Trading NewsIndivior (LON:INDV) Morning Trade VolumesShare Trading NewsIndivior PLC (Indivior) is a specialty pharmaceutical company. The Company and its subsidiaries are engaged in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence. It is engaged in ...
06/01/16 07:21 AMAre GlaxoSmithKline plc and Indivior plc the perfect pharma pairing? - Motley Fool UK - Are GlaxoSmithKline plc and Indivior plc the perfect pharma pairing?Motley Fool UKWhen faced with a choice between growth and income, what should you do? In the case of GlaxoSmithKline (LSE: GSK) and Indivior (LSE: INDV), the best answer might be to buy both. GlaxoSmithKline's appeal as a long-term income stock is no secret.and more »
05/31/16 04:47 PMAre GlaxoSmithKline plc and Indivior plc the perfect pharma pairing? - AOL Money UK - Are GlaxoSmithKline plc and Indivior plc the perfect pharma pairing?AOL Money UKWhen faced with a choice between growth and income, what should you do? In the case of GlaxoSmithKline (LSE: GSK) and Indivior (LSE: INDV), the best answer might be to buy both. GlaxoSmithKline's appeal as a long-term income stock is no secret.and more »
05/26/16 11:57 AMIndivior Annual General Meeting ... - [at noodls] - 05.11.2016 | PDF Version Indivior PLC ('Indivior' or the 'Company') Annual Report & Accounts 2015 and Annual General Meeting 2016 The Company has today posted or made available to shareholders the following ...
05/26/16 11:57 AMNotice of Annual General Meeting... - [at noodls] - Notice of Annual General Meeting...
05/26/16 11:47 AMIndivior Receives FDA Fast Track Designation for RPB-6000 Buprenorphine Monthly Depot for the Treatment of Opioid Use Disorder... - [at noodls] - 05.26.2016 | PDF Version Slough, UK, May 26, 2016 - Indivior Inc., a subsidiary of Indivior PLC (LON: INDV), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation ...
05/19/16 03:40 AMIndivior Plc breached its 50 day moving average in a Bullish Manner : INDV-GB : May 19, 2016 -
05/12/16 02:36 PMETF’s with exposure to Indivior Plc : May 12, 2016 -
05/09/16 01:19 AMIndivior Plc :INDV-GB: Earnings Analysis: Q1, 2016 By the Numbers -
05/02/16 07:28 PMIndivior shares slump as it posts drop in Q1 profit -
04/29/16 03:42 AMIndivior Plc breached its 50 day moving average in a Bearish Manner : INDV-GB : April 29, 2016 -
04/18/16 04:09 PMETF’s with exposure to Indivior Plc : April 18, 2016 -
02/19/16 07:13 AMEdited Transcript of INDV.L earnings conference call or presentation 18-Feb-16 12:00pm GMT -
02/19/16 03:32 AMIndivior Plc breached its 50 day moving average in a Bullish Manner : February 19, 2016 -
02/18/16 06:07 AMQ4 2015 Indivior PLC Earnings Release - 02:00 am ET -
12/07/15 03:12 AMIndivior agrees to repurchase $75m debts -
11/04/15 08:03 AMEdited Transcript of INDV.L earnings conference call or presentation 3-Nov-15 1:00pm GMT -
11/03/15 06:07 AMQ3 2015 Indivior PLC Earnings Release - 07:00 am ET -
About Indivior PLC

Indivior PLC logoIndivior PLC (Indivior) is a specialty pharmaceutical company. The Company and its subsidiaries are engaged in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine overdose and the co-morbidity of schizophrenia. Indivior's products include Suboxone film (buprenorphine and naloxone), Suboxone tablet (buprenorphine and naloxone), and Subutex tablet (buprenorphine sublingual tablet), all of which are treatments for opioid dependence. Suboxone film is a pharmaceutical prescription sublingual film product for buprenorphine-based opioid dependence treatment (based on equivalent volume of prescribed milligrams). Suboxone tablet is a fixed-dose combination of buprenorphine and naloxone in the ratio of four parts buprenorphine to one part naloxone. Subutex tablet is used for the treatment of opioid dependence.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: INDV
  • CUSIP:
Key Metrics:
  • Previous Close: $3.06
  • 50 Day Moving Average: $192.38
  • 200 Day Moving Average: $172.36
  • P/E Ratio: 8.56
  • P/E Growth: -0.26
  • Market Cap: $1.67B
  • Current Quarter EPS Consensus Estimate: $0.25 EPS
Additional Links:

            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha